Back to News
Market Impact: 0.3

JNJ Factor-Based Stock Analysis

JNJNDAQ
Company FundamentalsAnalyst InsightsHealthcare & BiotechMarket Technicals & FlowsInvestor Sentiment & Positioning
JNJ Factor-Based Stock Analysis

Validea's guru fundamental report indicates that Johnson & Johnson (JNJ) scores highly (87%) based on their Multi-Factor Investor model, which is based on the investment strategy of Pim van Vliet. This model favors low volatility stocks with strong momentum and high net payout yields; JNJ passes tests for market cap and standard deviation, but is neutral on momentum and net payout yield. Van Vliet's approach focuses on the outperformance of low volatility stocks with less risk, as detailed in his book "High Returns From Low Risk: A Remarkable Stock Market Paradox."

Analysis

Johnson & Johnson (JNJ) is highlighted by Validea as rating highest among stocks evaluated using its Multi-Factor Investor model, based on Pim van Vliet's strategy, achieving an 87% score; this score suggests significant alignment with the model's emphasis on low volatility, strong momentum, and high net payout yields from a quantitative perspective. The company satisfies the model's criteria for market capitalization and standard deviation, underscoring its low volatility characteristic, which is a core tenet of van Vliet's philosophy. However, JNJ demonstrates neutral performance for two other key factors in this strategy: "twelve minus one momentum" and "net payout yield." Critically, despite this top rating and high quantitative score, the detailed strategy tests culminate in a "FINAL RANK: FAIL" for JNJ, indicating that it does not meet all the discrete, potentially conjunctive, requirements necessary for a full endorsement under this specific Pim van Vliet framework. This presents a nuanced situation where JNJ exhibits strong appeal on certain model components, particularly low risk, but falls short on others, leading to an overall disqualification according to the strategy's specific implementation rules.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

moderately positive

Sentiment Score

0.60

Ticker Sentiment

JNJ0.70
NDAQ0.00

Key Decisions for Investors

  • Investors should carefully weigh Johnson & Johnson's high 87% quantitative score and top rating under the Pim van Vliet model against its "FINAL RANK: FAIL", which suggests that while attractive on some metrics like low volatility, it does not holistically satisfy all criteria of this specific multi-factor strategy.
  • The neutral ratings on "twelve minus one momentum" and "net payout yield" are significant drawbacks within this particular investment framework, indicating JNJ may not be optimal for investors strictly seeking the combined benefits of low volatility, strong momentum, and high yield as defined by the van Vliet strategy.
  • Given the "FAIL" status despite a high score, investors employing or considering similar conservative, multi-factor approaches should investigate whether JNJ's specific factor exposures align with their portfolio objectives or if alternative securities that pass all strategy tests would be more suitable.